Abstract Details
|
Julien F. Bally, MD
(CHUV Centre Hospitalier Universitaire Vaudois)
PRESENTER |
No disclosure on file |
| Sarah Camargos, MD (Neurology Movement Disorder Clinic,FD) | No disclosure on file |
| Laurie J. Ozelius, PhD | The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| Anthony E. Lang, MD, FÂé¶¹´«Ã½Ó³» (Toronto Western Hospital) | Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care. |